Statistics

Total Visits

Views
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects. 244

Total Visits Per Month

June 2024 July 2024 August 2024 September 2024 October 2024 November 2024 December 2024
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects. 6 0 8 8 0 2 0

File Visits

Views
rincon-onc-pp2a.pdf 547

Top country views

Views
United States 132
France 28
Germany 26
Spain 10
Belgium 7
United Kingdom 5
Ireland 5
Australia 4
Czech Republic 4
Italy 4

Top cities views

Views
Fairfield 21
Mountain View 17
Ashburn 12
Cambridge 10
San Ramon 10
Menlo Park 9
Barcelona 6
Ann Arbor 5
Dublin 5
San Diego 5

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking